StudySmarter: Study help & AI tools
4.5 • +22k Ratings
More than 22 Million Downloads
Free
|
|
Monoclonal Antibodies

Monoclonal antibodies are a specific, single type of antibody. The prefix 'mono-' means 'one', and the ending 'clonal' indicates that these antibodies are clones of each other; they are all the same. Scientists can clone B cells to produce monoclonal antibodies, where each antibody is produced from copies of the same cell. 

Mockup Schule Mockup Schule

Explore our app and discover over 50 million learning materials for free.

Monoclonal Antibodies

Illustration

Lerne mit deinen Freunden und bleibe auf dem richtigen Kurs mit deinen persönlichen Lernstatistiken

Jetzt kostenlos anmelden

Nie wieder prokastinieren mit unseren Lernerinnerungen.

Jetzt kostenlos anmelden
Illustration

Monoclonal antibodies are a specific, single type of antibody. The prefix 'mono-' means 'one', and the ending 'clonal' indicates that these antibodies are clones of each other; they are all the same. Scientists can clone B cells to produce monoclonal antibodies, where each antibody is produced from copies of the same cell.

How are monoclonal antibodies produced?

Monoclonal antibodies are produced 'naturally' in the body during the immune response, specifically the humoral response. Here, monoclonal antibodies are produced by one type of B cell (B lymphocyte), which synthesises the specific antibody that is complementary to the antigen of the pathogen being responded to. You can learn more about how and why B cells produce antibodies in our article on the humoral response.

Producing antibodies in a laboratory

Monoclonal antibodies can also be manufactured in laboratories for use in scientific research and medicine. In medical environments, they can be produced using hybridoma techniques.

A hybridoma is a hybrid cell used for the production of antibodies. It is a hybrid between a tumour cell and an antibody-producing lymphocyte.

In this process, a mouse is injected with an antigen for which a complementary antibody is being produced. This triggers a natural immune response in the mouse. The mouse's lymphocytes produce antibodies specific to the antigen.

Then, the spleen cells of the mouse, which synthesise the antibody-producing lymphocytes, are removed in a small operation.

These spleen cells are fused with human myeloma cells, which are cancerous white blood cells. The point of using cancerous cells is that they divide rapidly, and so many copies of this fused cell can be created in a short amount of time.

This fusion forms hybridoma cells that indefinitely divide to produce millions of antibodies. These antibodies are all identical to one another and specific to the original antigen.

Advantages and disadvantages

An advantage of this method is that scientists are able to produce large amounts of antibodies for use in research and medicine. Once a hybridoma cell has been produced, researchers can harvest virtually an endless amount of the antibodies required.

However, a clear disadvantage of this method is the ethical issues involved. Animals used in research cannot consent to the experiments being performed on them. Although steps are usually taken to reduce the pain they experience, lab animals may still experience pain during procedures such as surgeries.

What are monoclonal antibodies used for?

Monoclonal antibodies have significant value in science and medicine, where they can be used for testing for specific disease-causing antigens and for delivering targeted medication. Monoclonal antibodies are used to diagnose diseases such as HIV and conditions such as pregnancy.

Direct monoclonal antibody therapy

Monoclonal antibodies can be used to target specific cell types, such as cancer cells. Those that are complementary to the antigens on cancer cells can be given to patients. The attachment of monoclonal antibodies to the antigens on cancer cells blocks the chemical signals which stimulate their uncontrolled growth.

This prevents tumours from growing and spreading around the body, allowing for targeted chemotherapy to be more effective at destroying cancerous cells and preventing the progression of cancer. An example of this is the use of the Herceptin monoclonal antibody to treat breast cancer.

Direct monoclonal antibody therapy is currently one of the most successful cancer treatments. An advantage of this type of therapy is that it causes far fewer side effects than other types of monoclonal antibody therapy because the antibodies are non-toxic and highly specific.

Monoclonal Antibodies diagram of monoclonal antibodies attached to antigens on a cancer cell StudySmarterFig. 1 - Diagram of monoclonal antibodies attached to antigens on a cancer cell

Indirect monoclonal antibody therapy

Another method of treating cancer is the use of indirect monoclonal antibody therapy. This is when a radioactive or cytotoxic drug is attached to the monoclonal antibodies introduced into patients. When the antibody attaches to the antigens on cancer cells, it kills the cells.

Again, an advantage of this type of therapy is that it is highly specific, so only cancer cells are targeted. However, the use of toxic drugs may cause more side effects for patients. Another key advantage of both direct and indirect monoclonal antibody therapies is that they can be used in much smaller doses than other medications because they are specific. This saves money and reduces the chance of side effects.

Using monoclonal antibodies for medical diagnosis

Monoclonal antibodies are used in over a hundred different diagnostic products. This includes the ELISA test (Enzyme-linked immunosorbent assay), which has been developed to diagnose several diseases, including HIV and hepatitis B and C. Monoclonal antibodies are also used to diagnose diseases, such as influenza and chlamydia.

Monoclonal antibodies are important in helping to identify the presence of certain cancers, such as prostate cancer. Men with prostate cancer often produce a higher amount of a prostate-specific antigen (PSA). Doctors can use specific monoclonal antibodies to measure the amount of PSA in a person's blood. If this is unusually high, it may indicate the presence of cancer in the prostate, and give evidence for further diagnostic tests.

Monoclonal antibodies and pregnancy testing

Monoclonal antibodies are also used in pregnancy tests. When a pregnancy is diagnosed early, people can adjust their lifestyle accordingly to accommodate their growing child (eg by not drinking) or, if the pregnancy is unwanted, make plans to get an abortion before the fetus has developed past the point at which it is still legal. Therefore, having easy access to pregnancy tests is crucial. Monoclonal antibodies have made it possible to develop tests that can be taken at home and are relatively inexpensive.

These tests work by identifying the hormone human chorionic gonadotropin (hCG), which is produced by the placenta during pregnancy. This hormone can be found in the urine of pregnant people. If hCG is present, it will bind to the complementary antibodies on the testing strip of the pregnancy test. These antibodies are linked to coloured particles. The hCG-antibody-color complex then moves up along the testing strip until trapped by a second antibody, which produces a coloured line, indicating a positive test. This is broadly how lateral flow tests for COVID-19 operate, too.

Monoclonal Antibodies results for a positive pregnancy test monoclonal antibodies StudySmarterFig. 2 - How a positive pregnancy test occurs

Monoclonal antibodies and ethical usage

While the use of monoclonal antibodies is undoubtedly beneficial in diagnosing and treating certain conditions, there are also ethical issues associated with their development and usage.

As seen previously, monoclonal antibodies are most commonly produced using mice. In this process, mice are exposed to non-self material, including diseases. For instance, B cells in mice may be mixed with cancer cells to ensure their B cells duplicate quickly. While steps are taken to minimize the suffering of the animals involved, questions are raised as to how ethical it is to induce cancer and potentially other diseases in animals that cannot consent to their testing. It must also be asked if patients should be told if the monoclonal antibodies used for their treatment have come from genetically modified animals.

In some methods of production, monoclonal antibodies are produced from B cells donated by humans. With this method, is it right to keep donors anonymous, or should patients be able to find out where the B cells used in their treatment have come from?

In some cases, the monoclonal antibodies in disease treatment have been associated with severe side effects and even deaths.

An example of this has been in the treatment of multiple sclerosis. Should people with this condition be denied treatments that use monoclonal antibodies because of the potential risk they pose? As with all medical treatments, informed consent requires that patients must be fully informed of the risks and benefits of the drugs being administered so they can give permission for them to be used.

Monoclonal Antibodies - Key takeaways

  • Monoclonal antibodies are a specific, singular type of antibody. They are all identical or clones of each other.

  • Monoclonal antibodies are produced in the humoral immune response by B cells. They can also be manufactured in laboratories by using hybridoma techniques. This is when antibody-producing lymphocytes in mice are fused with human cancer cells to produce large quantities of specific monoclonal antibodies.

  • Monoclonal antibodies can be used to treat diseases, such as cancer. They can bind directly to specific cancerous cells. Once bound, they can either act to block chemical signals that promote cancerous growth, or they can deliver targeted medication that has been attached to the antibodies.

  • Monoclonal antibodies can also be used to diagnose certain diseases and conditions. They are used in the ELISA test, to diagnose HIV, and in pregnancy test kits.

  • Monoclonal antibodies may cause adverse side effects when used in medical treatment. Patients receiving them must always be made fully aware of the risks and benefits of the treatment being offered so they can give their consent.

Frequently Asked Questions about Monoclonal Antibodies

Monoclonal antibodies are a specific, single type of antibody where all antibodies are identical to one another. This is because they are clones of one another and are produced by the same B cell.

Monoclonal antibodies are produced by B cells. They can be manufactured for medical use involving mice. In this method, mice are exposed to some non-self material, which causes their B cells to produce antibodies. These B cells are then fused with cancer cells so they divide rapidly, forming hybridoma cells, from which antibodies can be extracted.

Monoclonal antibodies can be used to treat diseases, such as cancer. They can also be used to diagnose diseases or conditions, such as HIV and pregnancy.

Monoclonal antibodies work by binding directly to specific complementary antigens on the surface of cells or foreign material. Medicines can be attached to monoclonal antibodies to deliver targeted drugs to specific cells in the body, such as cancer cells.

Monoclonal antibodies can bind directly to specific cancerous cells. Once bound, they can either act to block chemical signals that promote cancerous growth, or they can deliver targeted medication that has been attached to the antibodies.

Join over 22 million students in learning with our StudySmarter App

The first learning app that truly has everything you need to ace your exams in one place

  • Flashcards & Quizzes
  • AI Study Assistant
  • Study Planner
  • Mock-Exams
  • Smart Note-Taking
Join over 22 million students in learning with our StudySmarter App Join over 22 million students in learning with our StudySmarter App

Sign up to highlight and take notes. It’s 100% free.

Start learning with StudySmarter, the only learning app you need.

Sign up now for free
Illustration

Entdecke Lernmaterial in der StudySmarter-App